Figure 5.

Body weight change, blood cell counts and AST/ALT levels on day 21 in KRASm/TP53w HCT116 xenograft model. A, Body weight change during curcumin, curcumin β‐D‐glucuronide (CMG) and L‐OHP treatment. **P < 0.01, as compared to the control, curcumin and CMG group on day 21. B, Blood cell counts on day 21. *P < 0.01, as compared to the control and CMG groups. C, AST/ALT levels on day 21 *P < 0.05, **P < 0.01, #P < 0.01 and ##P < 0.05, as compared to the control. ***P < 0.05, as compared to the L‐OHP group